Computational engineering of EB peptide to unravel potential mpox entry blockers through in silico saturation mutagenesis
Biomedical Engineering Communications · 2027 · 6 (1) · 3
DOI: 10.53388/bmec2027003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Engineering Communications, 2027. Verfasst von Leana Rich Herrera-Ong.
Abstract (Originalsprache)
Background
The emergence of Mpox highlights the lack of virus-specific antivirals, as current agents offer limited efficacy and pose toxicity risks. Entry blocker (EB) peptide blocks Orthopoxvirus entry but is effective only when co-administered with the virus and shows no prophylactic or therapeutic benefit against vaccinia virus in vivo . Thus, this study applied in silico saturation mutagenesis to produce EB-derived peptides with enhanced affinity and stability toward Mpox A29L, M1R, A35R, and B6R surface proteins.
Methods
The tertiary structure models for the target Mpox surface proteins were generated and validated prior to molecular docking. In silico saturated mutagenesis was conducted to analyze for critical residues that can aid in peptide-protein binding enhancement. Potentially toxic peptides were also identified and excluded. The dissociation constant (K D ) and Gibbs free energy of binding (ΔG bind ) were calculated. The values of differential binding energy (ΔΔG) were also determined to uncover candidate peptides.
Results
High-quality tertiary structure models enabled reliable docking, revealing fifteen EB-derived peptides with stronger binding affinity than the wild-type EB (WTEB) peptide. Peptides predicted to interact with potentially glycosylated sites were determined, refining the set to eleven candidate peptides, including six candidates which demonstrated large binding enhancement (ΔΔG > 1 kcal/mol). Results from molecular dynamics analysis further verify that A29L3W and A29L8W can form more stable, well-equilibrated complexes with Mpox A29L than the WTEB. In addition, candidate peptides M1R1E and B6RCom displayed favorable physicochemical stability.
Conclusion
Overall, the computational workflow developed and applied in this research presents eleven EB-derived candidate peptides as promising Mpox entry inhibitors, pending subsequent in vitro and clinical studies.
Zitieren
APA
Herrera-Ong, L. R. (2027). Computational engineering of EB peptide to unravel potential mpox entry blockers through in silico saturation mutagenesis. Biomedical Engineering Communications, 6(1), 3. https://doi.org/10.53388/bmec2027003
Vancouver
Herrera-Ong LR. Computational engineering of EB peptide to unravel potential mpox entry blockers through in silico saturation mutagenesis. Biomedical Engineering Communications. 2027;6(1):3. doi:10.53388/bmec2027003
BibTeX
@article{HerreraOng2027,
author = {Herrera-Ong, Leana Rich},
title = {Computational engineering of EB peptide to unravel potential mpox entry blockers through in silico saturation mutagenesis},
journal = {Biomedical Engineering Communications},
year = {2027},
volume = {6},
number = {1},
pages = {3},
doi = {10.53388/bmec2027003}
}
EUVIMED